FDA approves first drug for form of thyroid cancer

The drug, vandetanib, helped stall the disease's progression for an average of six months, the Food and Drug Administration says.WASHINGTON — Federal regulators Wednesday approved the first drug treatment for a rare form of late-stage thyroid cancer.

Read the whole article on LA Times - Science

More from LA Times - Science